xRead - September 2022

Wise et al.

Page 459

Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Study Year LOE Study design Study groups Clinical endpoint Conclusion Shedden 2026 2005 3b Case-control AR, adults and children (n = 2355) Direct sleep questions >80% with NC affected in some way at night, primarily causing them to wake up or made it difficult to fall asleep. Stuck et al. 731 2004 3b Controlled trial SAR, adults (n = 50) ESS, SF-36, PSG SAR increases daytime sleepiness, and worsens QOL. Stull et al. 682 2009 4 Case series AR, adults (n = 404) MOS-Sleep, NRQLQ, WPAI-AS, PANAS-X

Those with more severe NC or ocular symptoms report poorer scores on sleep domains.

McNicholas et al. 718 1982 4 Case- series SAR, adults (n = 7) PSG In patients with SAR, obstructive sleep apneas are more frequent during a period of symptomatic nasal obstruction.

AR = allergic rhinitis; ESS = Epworth Sleepiness Scale; FOSQ = Functional Outcomes of Sleep; INCS = intranasal corticosteroid; LOE = level of evidence; mini-RQLQ = mini-Rhinoconjunctivitis Quality of Life Questionnaire; MOS-Sleep = Sleep Scale from the Medical Outcomes Study; NC = nasal congestion; NRQLQ = Nocturnal Rhinoconjunctivitis Quality of Life Questionnaire; PANAS-X = Positive and Negative Affect Schedule-Expanded Form; PAR = perennial allergic rhinitis; PDSS = Pediatric Daytime Sleepiness Scale; PSG = polysomnogram; PSQ = Pediatric Sleep Questionnaire; PSQI = Pittsburgh Sleep Quality Index; QOL = quality of life; RCT = randomized controlled trial; RQLQ = Rhinoconjunctivitis Quality of Life Questionnaire; RQLQ-S = Standardized Rhinoconjunctivitis Quality of Life Questionnaire; RSDI = Rhinosinusitis Disability Index; SAR = seasonal allergic rhinitis; SDB = sleep disordered breathing; SF-36 = Medical Outcomes Study 36-item Short Form health survey; SSS = Stanford Sleepiness Score; WPAI-AS = Work Productivity and Activity Impairment Questionnaire-Allergy-Specific.

Int Forum Allergy Rhinol . Author manuscript; available in PMC 2020 June 10.